The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Self-citationThe X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
Picot, D., Loll, P. J., & Garavito, R. M. (1994) · Nature · doi:10.1038/367243a0 · Cited by 1,265
Portanova, J. P., Zhang, Y., Anderson, G. D., Hauser, S. D., Masferrer, J. L., Seibert, K., Gregory, S. A., & Isakson, P. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.883 · Cited by 421
Zhang, Y., Shaffer, A., Portanova, J., Seibert, K., & Isakson, P. C. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37166-6 · Cited by 229
Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors
Gierse, J. K., Nickols, M. A., Leahy, K., Warner, J. D., Zhang, Y., Cortes-Burgos, L. A., Carter, J., Seibert, K., & Masferrer, J. L. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.057 · Cited by 35
Self-citation
Cited by
Classification of scaffold-hopping approaches
Sun, H., Tawa, G., & Wallqvist, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.024 · Cited by 375
Kaserer, T., Temml, V., Kutil, Z., Vanek, T., Landa, P., & Schuster, D. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.017 · Cited by 23
Metadata
- Authors
- Wang, J. L., Limburg, D., Graneto, M. J., Springer, J., Hamper, J. R. B., Liao, S., Pawlitz, J. L., Kurumbail, R. G., Maziasz, T., Talley, J. J., Kiefer, J. R., & Carter, J.
- Venue
- Bioorganic & Medicinal Chemistry Letters
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 20
- Issue
- 23
- Pages
- 7159-7163
- ISSN
- 0960-894X (ISSN-L)
- OpenAlex
- W2112845321
- Cited by
- 337
- References
- 5
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life. https://app.cochat.ai/papers/10.1016/j.bmcl.2010.07.054
- The paper
- Wang, J. L., Limburg, D., Graneto, M. J., Springer, J., Hamper, J. R. B., Liao, S., Pawlitz, J. L., Kurumbail, R. G., Maziasz, T., Talley, J. J., Kiefer, J. R., & Carter, J. (2010). The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2010.07.054
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
